Effects of ketoconazole on digoxin absorption and disposition in rat

Pharmacology

Volumn 56, Issue 6, 1998, Pages 308-313

  Salphati, Laurent ^a   Benet, Leslie Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Digoxin; Ketoconazole; P glycoprotein; Pharmacokinetics; Rat

Indexed keywords

CYTOCHROME P450; DIGOXIN; KETOCONAZOLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIGOXIN BLOOD LEVEL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG ELIMINATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIDRUG RESISTANCE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CARDIOTONIC AGENTS; DIGOXIN; INTESTINAL ABSORPTION; KETOCONAZOLE; MALE; RATS;

EID: 0031861258     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028214     Document Type: Article

References (31)

1. Leveille-Webster CR, Arias IM: The biology of the P-glycoproteins. J Membr Biol 1995;143:89-102.
2. Chin KV, Pastan I, Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Cancer Res 1993;60:157-180.
3. Borst P, Schinkel AH, Smit JJ, Wagenaar E, van Deemter L, Smith AJ, Eijdems EW, Baas F, Zaman GJ: Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther 1993; 60:289-299.
4. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
5. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR: Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-1287.
6. Silverman JA, Thorgeirsson SS: Regulation and function of the multidrug resistance genes in liver; in Boyer JL, Ockner RK (eds): Progress in Liver Diseases. Philadelphia, Saunders, 1995, pp 101-123.
7. Ruetz S, Gros P: Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 1994;77: 1071-1081.
8. Smit JW, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM, van Roon MA, Offerhaus GJA, Berns AJM, Borst P: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-462.
9. Silverman JA, Schrenk D: Hepatic canalicular membrane. 4. Expression of the multidrug resistance genes in the liver. FASEB J 1997;11: 308-313.
10. 450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995;13:129-134.
11. Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R: Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 1992;263:840-845.
12. Su SF, Huang JD: Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab Dispos 1996;24:142-147.
13. Hori R, Okamura N, Aiba T, Tanigawara Y: Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. J Pharmacol Exp Ther 1993;266: 1620-1625.
14. Mayer U, Wagenaar E, Beijnen JH, Smit JW, Meijer DK, van Asperen J, Borst P, Schinkel AH: Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein. Br J Pharmacol 1996;119:1038-1044.
15. Harrison LI, Gibaldi M: Pharmacokinetics of digoxin in the rat. Drug Metab Dispos 1976;4:88-93.
16. 450 3A. Drug Metab Dispos 1998, submitted.
17. 450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 1995;23:154-158.
18. Siegsmund MJ, Cardarelli C, Aksentijevich I, Sugimoto Y, Pastan I, Gottesman MM: Ketoconazole effectively reverses multidrug resistance in highly resistant KB cells. J Urol 1994;151:485-491.
19. Upton RA: Simple and reliable method for serial sampling of blood from rats. J Pharm Sci 1975;64: 112-114.
20. Benet LZ, Galeazzi RL: Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 1979;68:1071-1074.
21. Staubus AE, Smith SF: Concept of time-averaged clearance and mean residence time in Michaelis-Menten elimination system; in Benet LZ, Levy G, Ferraiolo BL (eds): Pharmacokinetics - A Modern View. New York, Plenum Press, 1984, pp 411-414.
22. Cheng HY, Jusko WJ: Application of mean residence-time concepts to pharmacokinetic systems with non-instantaneous input and nonlinear elimination. Pharm Res 1989;6:4-12.
23. Lown KS, Kolars JC, Ghosh M, Schmiedlin-Ren P, Watkins PB: Induction of MDR1 expression in normal rat and human intestine in vivo. Gastroenterology 1996;110:A344.
24. Rietbrock N, Abshagen U, Bergmann KV, Kewitz H: Pharmacokinetics of digoxin and its 4′-acetyl-and methylderivates in the rat. Naunyn Schmiedebergs Arch Pharmacol 1972;274:171-181.
25. Balkon J, Donnelly B: Comparative kinetics of digoxin in serum and vitreous humor in a guinea pig model. II. Single oral dose administration. J Anal Toxicol 1992;16:155-157.
26. Evans RL, Owens SM, Ruch S, Kennedy RH, Seifen E: The effect of age on digoxin pharmacokinetics in Fischer-344 rats. Toxicol Appl Pharmacol 1990;102:61-67.
27. Weinhouse E, Kaplanski J, Zalzstein E, Genchik G, Colton D, Nudel D: Mechanisms of digoxin-amiodarone interaction in the rat. Proc Soc Exp Biol Med 1988;188:96-102.
28. Braunschweig J, Stäubli M, Studer H: Interactions of amiodarone with digoxin in rats. Br J Pharmacol 1987;92:553-559.
29. Weinhouse E, Kaplanski J, Genchik G: Plasma and tissue levels of digoxin in the rat following pretreatment with verapamil. Res Commun Chem Pathol Pharmacol 1985; 47:469-472.
30. Ford JM, Hait WN: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990;42:155-199.
31. Lacarelle B, Rahmani R, de Sousa G, Durand A, Placidi M, Cano JP: Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundam Clin Pharmacol 1991;5:567-582.